Pádraig Rice (Cork South-Central, Social Democrats)
Link to this: Individually | In context

1511. To ask the Minister for Health the number of patients receiving biologics medicines for severe asthma in 2024 and to date in 2025; and the specific biologic medicines included, in tabular form. [29978/25]

Jennifer Carroll MacNeill (Dún Laoghaire, Fine Gael)
Link to this: Individually | In context

As this is a service matter, I have asked the Health Service Executive to respond to the Deputy directly, as soon as possible.

Pádraig Rice (Cork South-Central, Social Democrats)
Link to this: Individually | In context

1512. To ask the Minister for Health the number of patients receiving biologic medicines for severe asthma in 2024 and to date in 2025, by health region and hospital, in tabular form. [29979/25]

Jennifer Carroll MacNeill (Dún Laoghaire, Fine Gael)
Link to this: Individually | In context

As this is a service matter, I have asked the Health Service Executive to respond to the Deputy directly, as soon as possible.

Pádraig Rice (Cork South-Central, Social Democrats)
Link to this: Individually | In context

1513. To ask the Minister for Health the status of the commissioned managed access protocol necessary for the reimbursement of a severe asthma biologic medicine for patients with EOS level greater than 300 (details supplied); the delivery timeline; and if she will make a statement on the matter. [29980/25]

Jennifer Carroll MacNeill (Dún Laoghaire, Fine Gael)
Link to this: Individually | In context

Under the Health (Pricing and Supply of Medical Goods) Act 2013, the HSE has statutory responsibility for decisions on the pricing and reimbursement of medicines and medical devices; therefore, the matter has been referred to the HSE for attention and direct reply to the Deputy.

Pádraig Rice (Cork South-Central, Social Democrats)
Link to this: Individually | In context

1514. To ask the Minister for Health the status of the health technology assessment ongoing with the National Centre for Pharmacoeconomics for a biologic medicine to be used for severe asthma patients with EOS level less than 300 (details supplied); the delivery timeline; and if she will make a statement on the matter. [29981/25]

Jennifer Carroll MacNeill (Dún Laoghaire, Fine Gael)
Link to this: Individually | In context

Under the Health (Pricing and Supply of Medical Goods) Act 2013, the HSE has statutory responsibility for decisions on the pricing and reimbursement of medicines and medical devices; therefore, the matter has been referred to the HSE for attention and direct reply to the Deputy.